---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-23-007073"
form_type: "8-K"
ticker: "AGPU"
cik: "0001446159"
company_name: "Axe Compute Inc."
filed_at: "2023-11-14T23:59:59+00:00"
generated_at: "2026-06-08T03:22:48.162731+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Predictive Oncology narrows Q3 net loss 22% to $3.2M; revenue rises 57% to $715K

## Summary
- Net loss of $3.2M ($0.78 per share) vs $4.1M ($1.04) in Q3 2022, a 22% reduction.
- Revenue of $715,056, up 57% YoY, driven by higher sales of 3-D models.
- Gross margin improved to 85% from 76%; G&A expenses decreased $704K to $2.58M.
- Cash and equivalents $11.9M (down from $22.1M at Dec 31, 2022); equity $11.7M.
- Milestone: accurately predicted cancer types responsive to CRH's glutaminase inhibitors; ovarian cancer study with UPMC.

## SEC filing metadata
- accession: 0001171843-23-007073
- form_type: 8-K
- ticker: AGPU
- cik: 0001446159
- company_name: Axe Compute Inc.
- filed_at: 2023-11-14T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1446159/000117184323007073/0001171843-23-007073-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1446159/000117184323007073/f8k_111323.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-23-007073
- JSON: https://secwatch.observer/filing/0001171843-23-007073.json
- Plain text: https://secwatch.observer/filing/0001171843-23-007073.txt

## Key facts
- Earnings Releases
  Axe Compute Inc. reported three months ended September 30, 2023 results: revenue $715,056, EPS $0.78.
  - Period: three months ended September 30, 2023
  - Revenue: $715,056
  - EPS: $0.78
  - Result: reported results
  source text: Predictive Oncology recorded revenue of $715,056 in the third quarter of 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1446159/000117184323007073/0001171843-23-007073-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.